KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$6000.0.

  • Xenon Pharmaceuticals' Exchange Rate Effect fell 11111.11% to -$6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$595000.0, marking a year-over-year decrease of 12118.96%. This contributed to the annual value of -$1.7 million for FY2024, which is 54468.09% down from last year.
  • Xenon Pharmaceuticals' Exchange Rate Effect amounted to -$6000.0 in Q3 2025, which was down 11111.11% from $632000.0 recorded in Q2 2025.
  • Xenon Pharmaceuticals' 5-year Exchange Rate Effect high stood at $814000.0 for Q4 2022, and its period low was -$2.7 million during Q3 2022.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$6000.0 (2025), whereas its average is -$200526.3.
  • As far as peak fluctuations go, Xenon Pharmaceuticals' Exchange Rate Effect soared by 107971.01% in 2022, and later crashed by 72203.39% in 2024.
  • Xenon Pharmaceuticals' Exchange Rate Effect (Quarter) stood at $69000.0 in 2021, then skyrocketed by 1079.71% to $814000.0 in 2022, then plummeted by 69.78% to $246000.0 in 2023, then plummeted by 570.33% to -$1.2 million in 2024, then surged by 99.48% to -$6000.0 in 2025.
  • Its last three reported values are -$6000.0 in Q3 2025, $632000.0 for Q2 2025, and -$64000.0 during Q1 2025.